Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 13 | 2021 | 280 | 2.590 |
Why?
|
| Ethanol | 18 | 2022 | 134 | 2.220 |
Why?
|
| Gastrointestinal Microbiome | 10 | 2023 | 180 | 2.070 |
Why?
|
| Methamphetamine | 5 | 2013 | 48 | 1.680 |
Why?
|
| Colon | 10 | 2023 | 148 | 1.580 |
Why?
|
| Intestinal Mucosa | 12 | 2019 | 220 | 1.540 |
Why?
|
| Dysbiosis | 8 | 2022 | 64 | 1.430 |
Why?
|
| Intestines | 10 | 2022 | 107 | 1.400 |
Why?
|
| Animals | 31 | 2023 | 4552 | 1.010 |
Why?
|
| Parkinson Disease | 7 | 2023 | 1164 | 0.980 |
Why?
|
| Multiple System Atrophy | 2 | 2022 | 42 | 0.980 |
Why?
|
| Central Nervous System Stimulants | 4 | 2013 | 52 | 0.980 |
Why?
|
| Liver | 4 | 2017 | 173 | 0.900 |
Why?
|
| Circadian Clocks | 4 | 2021 | 31 | 0.880 |
Why?
|
| Gastrointestinal Diseases | 2 | 2019 | 43 | 0.840 |
Why?
|
| Conditioning, Operant | 2 | 2011 | 15 | 0.800 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2021 | 6 | 0.800 |
Why?
|
| Veterans | 1 | 2022 | 63 | 0.800 |
Why?
|
| Carrier Proteins | 2 | 2021 | 97 | 0.790 |
Why?
|
| Membrane Glycoproteins | 2 | 2021 | 101 | 0.790 |
Why?
|
| Central Nervous System Depressants | 4 | 2019 | 24 | 0.780 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2021 | 39 | 0.780 |
Why?
|
| Alcoholism | 5 | 2022 | 83 | 0.760 |
Why?
|
| Liver Diseases, Alcoholic | 3 | 2017 | 45 | 0.760 |
Why?
|
| Photoperiod | 4 | 2021 | 43 | 0.720 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 189 | 0.710 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 55 | 0.670 |
Why?
|
| Mice, Inbred C57BL | 11 | 2023 | 432 | 0.660 |
Why?
|
| Microbiota | 5 | 2018 | 105 | 0.650 |
Why?
|
| Intestinal Absorption | 2 | 2017 | 42 | 0.650 |
Why?
|
| Binge Drinking | 1 | 2017 | 10 | 0.630 |
Why?
|
| Association Learning | 3 | 2013 | 14 | 0.610 |
Why?
|
| Chronobiology Disorders | 2 | 2017 | 14 | 0.600 |
Why?
|
| Mice | 16 | 2023 | 1607 | 0.570 |
Why?
|
| Immunity, Mucosal | 2 | 2019 | 29 | 0.570 |
Why?
|
| CLOCK Proteins | 5 | 2017 | 26 | 0.560 |
Why?
|
| Alcohol Drinking | 4 | 2019 | 78 | 0.560 |
Why?
|
| Male | 25 | 2022 | 15621 | 0.540 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 153 | 0.530 |
Why?
|
| Fendiline | 1 | 2013 | 2 | 0.490 |
Why?
|
| Space Perception | 1 | 2013 | 28 | 0.480 |
Why?
|
| Calcium Channel Blockers | 1 | 2013 | 36 | 0.470 |
Why?
|
| Inflammation | 4 | 2017 | 344 | 0.470 |
Why?
|
| Humans | 33 | 2023 | 29337 | 0.460 |
Why?
|
| Permeability | 10 | 2021 | 134 | 0.460 |
Why?
|
| Alcohol-Related Disorders | 1 | 2013 | 3 | 0.460 |
Why?
|
| Feces | 6 | 2023 | 98 | 0.450 |
Why?
|
| Behavior, Addictive | 2 | 2018 | 11 | 0.440 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 74 | 0.440 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 284 | 0.430 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 938 | 0.420 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2011 | 9 | 0.410 |
Why?
|
| Mianserin | 1 | 2011 | 15 | 0.410 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2013 | 451 | 0.400 |
Why?
|
| Baclofen | 1 | 2011 | 15 | 0.400 |
Why?
|
| Extinction, Psychological | 1 | 2011 | 15 | 0.400 |
Why?
|
| GABA-B Receptor Agonists | 1 | 2010 | 2 | 0.390 |
Why?
|
| Disease Models, Animal | 9 | 2023 | 724 | 0.370 |
Why?
|
| Time Factors | 6 | 2019 | 1616 | 0.360 |
Why?
|
| Feeding Behavior | 3 | 2019 | 100 | 0.350 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 1942 | 0.350 |
Why?
|
| Biomarkers | 4 | 2022 | 689 | 0.340 |
Why?
|
| HIV Infections | 2 | 2017 | 970 | 0.330 |
Why?
|
| Eating | 2 | 2018 | 45 | 0.310 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 2 | 2019 | 10 | 0.300 |
Why?
|
| Stem Cells | 2 | 2017 | 46 | 0.300 |
Why?
|
| Colon, Sigmoid | 2 | 2017 | 18 | 0.280 |
Why?
|
| Cytochrome P-450 CYP2E1 | 3 | 2014 | 13 | 0.280 |
Why?
|
| Rats | 4 | 2011 | 854 | 0.270 |
Why?
|
| Colitis | 2 | 2023 | 37 | 0.270 |
Why?
|
| Diet, High-Fat | 2 | 2015 | 17 | 0.260 |
Why?
|
| Butyrates | 2 | 2022 | 19 | 0.260 |
Why?
|
| Period Circadian Proteins | 4 | 2021 | 23 | 0.250 |
Why?
|
| Motor Activity | 4 | 2021 | 369 | 0.240 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 10 | 0.230 |
Why?
|
| Acute-Phase Proteins | 2 | 2021 | 14 | 0.230 |
Why?
|
| Neurosecretory Systems | 1 | 2022 | 9 | 0.220 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 11 | 0.220 |
Why?
|
| Nutritional Status | 1 | 2022 | 39 | 0.220 |
Why?
|
| Mindfulness | 1 | 2022 | 34 | 0.220 |
Why?
|
| Colitis, Ulcerative | 1 | 2022 | 66 | 0.210 |
Why?
|
| alpha-Synuclein | 2 | 2015 | 138 | 0.210 |
Why?
|
| Bacteria | 1 | 2022 | 77 | 0.210 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2018 | 33 | 0.200 |
Why?
|
| Oxidative Stress | 4 | 2017 | 124 | 0.200 |
Why?
|
| Fatty Liver | 2 | 2018 | 30 | 0.200 |
Why?
|
| Osteoarthritis, Knee | 2 | 2015 | 381 | 0.190 |
Why?
|
| Carcinogenesis | 2 | 2019 | 21 | 0.190 |
Why?
|
| Life Style | 1 | 2022 | 211 | 0.190 |
Why?
|
| Cartilage, Articular | 2 | 2015 | 524 | 0.190 |
Why?
|
| Memory, Short-Term | 1 | 2021 | 102 | 0.190 |
Why?
|
| Analysis of Variance | 2 | 2011 | 321 | 0.190 |
Why?
|
| Metabolic Syndrome | 1 | 2020 | 66 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 200 | 0.180 |
Why?
|
| Colonic Polyps | 1 | 2019 | 23 | 0.180 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 1 | 2019 | 4 | 0.180 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2017 | 56 | 0.180 |
Why?
|
| Chronotherapy | 1 | 2019 | 9 | 0.180 |
Why?
|
| Ileum | 2 | 2017 | 22 | 0.170 |
Why?
|
| Rotenone | 1 | 2018 | 10 | 0.170 |
Why?
|
| Female | 9 | 2021 | 16197 | 0.170 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2018 | 7 | 0.160 |
Why?
|
| Biopsy | 2 | 2017 | 234 | 0.160 |
Why?
|
| Aged | 5 | 2021 | 9448 | 0.160 |
Why?
|
| Bacterial Translocation | 2 | 2015 | 33 | 0.160 |
Why?
|
| Animal Feed | 1 | 2017 | 6 | 0.160 |
Why?
|
| Organoids | 1 | 2017 | 8 | 0.160 |
Why?
|
| Hypercholesterolemia | 1 | 2018 | 29 | 0.160 |
Why?
|
| Saliva | 1 | 2018 | 53 | 0.160 |
Why?
|
| Neoplasms | 1 | 2020 | 247 | 0.160 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2017 | 18 | 0.160 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 27 | 0.160 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 9 | 0.150 |
Why?
|
| Dementia | 1 | 2022 | 521 | 0.150 |
Why?
|
| Intestine, Small | 1 | 2017 | 33 | 0.150 |
Why?
|
| Amphetamine-Related Disorders | 2 | 2013 | 10 | 0.150 |
Why?
|
| Cytomegalovirus Infections | 1 | 2017 | 79 | 0.150 |
Why?
|
| Signal Transduction | 1 | 2019 | 482 | 0.140 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 25 | 0.140 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 254 | 0.140 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 82 | 0.140 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 8 | 0.130 |
Why?
|
| Chromatography, Gas | 1 | 2015 | 12 | 0.130 |
Why?
|
| Urinalysis | 1 | 2015 | 9 | 0.130 |
Why?
|
| Carbohydrates | 1 | 2015 | 14 | 0.130 |
Why?
|
| Joints | 1 | 2015 | 97 | 0.130 |
Why?
|
| Dietary Sucrose | 1 | 2014 | 7 | 0.130 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2015 | 52 | 0.130 |
Why?
|
| Rotarod Performance Test | 1 | 2013 | 8 | 0.120 |
Why?
|
| Avoidance Learning | 1 | 2013 | 9 | 0.120 |
Why?
|
| Light | 1 | 2014 | 76 | 0.120 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2013 | 11 | 0.120 |
Why?
|
| Hippocampus | 1 | 2015 | 274 | 0.110 |
Why?
|
| Treatment Outcome | 1 | 2022 | 3478 | 0.110 |
Why?
|
| Cognition | 1 | 2021 | 1277 | 0.110 |
Why?
|
| Knee Joint | 2 | 2015 | 797 | 0.110 |
Why?
|
| Adult | 5 | 2018 | 8601 | 0.110 |
Why?
|
| Endotoxins | 1 | 2011 | 24 | 0.100 |
Why?
|
| Receptors, GABA-B | 1 | 2011 | 3 | 0.100 |
Why?
|
| Memory | 1 | 2013 | 318 | 0.100 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2011 | 18 | 0.100 |
Why?
|
| Psychotherapy | 1 | 2011 | 34 | 0.100 |
Why?
|
| Brain | 3 | 2022 | 1689 | 0.100 |
Why?
|
| Self Administration | 1 | 2011 | 36 | 0.100 |
Why?
|
| Middle Aged | 5 | 2017 | 9823 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4851 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 223 | 0.100 |
Why?
|
| Cyclopentanes | 1 | 2010 | 4 | 0.100 |
Why?
|
| Phenols | 1 | 2010 | 8 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2010 | 21 | 0.100 |
Why?
|
| Osteoarthritis | 1 | 2015 | 363 | 0.100 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2011 | 88 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2019 | 26 | 0.080 |
Why?
|
| Neurons | 1 | 2011 | 374 | 0.080 |
Why?
|
| Epithelial Cells | 2 | 2019 | 87 | 0.080 |
Why?
|
| Disease Progression | 2 | 2022 | 787 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2017 | 676 | 0.070 |
Why?
|
| Environment | 2 | 2015 | 46 | 0.070 |
Why?
|
| Endotoxemia | 2 | 2015 | 29 | 0.070 |
Why?
|
| Proteoglycans | 2 | 2015 | 337 | 0.060 |
Why?
|
| Dextran Sulfate | 1 | 2023 | 11 | 0.060 |
Why?
|
| Prebiotics | 1 | 2023 | 16 | 0.060 |
Why?
|
| Fatty Acids, Volatile | 1 | 2023 | 30 | 0.060 |
Why?
|
| Dietary Supplements | 1 | 2022 | 53 | 0.050 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2021 | 15 | 0.050 |
Why?
|
| Luciferases | 1 | 2021 | 24 | 0.050 |
Why?
|
| Diet | 1 | 2022 | 174 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2022 | 246 | 0.050 |
Why?
|
| DNA Damage | 1 | 2019 | 30 | 0.040 |
Why?
|
| CD3 Complex | 1 | 2018 | 13 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 248 | 0.040 |
Why?
|
| Transcription Factor HES-1 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Keratin-20 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Jejunum | 1 | 2017 | 10 | 0.040 |
Why?
|
| Chromogranin A | 1 | 2017 | 13 | 0.040 |
Why?
|
| Occludin | 1 | 2017 | 13 | 0.040 |
Why?
|
| Receptor, Notch1 | 1 | 2017 | 7 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2018 | 303 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2017 | 12 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2017 | 13 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2017 | 12 | 0.040 |
Why?
|
| Cadherins | 1 | 2017 | 31 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2017 | 29 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2017 | 38 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 662 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 48 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 73 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 47 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2017 | 96 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 161 | 0.040 |
Why?
|
| Young Adult | 2 | 2015 | 1932 | 0.040 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2017 | 15 | 0.040 |
Why?
|
| Viral Load | 1 | 2017 | 197 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2018 | 638 | 0.040 |
Why?
|
| Mast Cells | 1 | 2016 | 26 | 0.040 |
Why?
|
| Risk Factors | 1 | 2022 | 2443 | 0.030 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2015 | 30 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 47 | 0.030 |
Why?
|
| Protein Folding | 1 | 2015 | 18 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 38 | 0.030 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 34 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 347 | 0.030 |
Why?
|
| Body Weight | 1 | 2015 | 133 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 80 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 21 | 0.030 |
Why?
|
| Homeostasis | 1 | 2015 | 82 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 46 | 0.030 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2014 | 11 | 0.030 |
Why?
|
| Probiotics | 1 | 2015 | 20 | 0.030 |
Why?
|
| Kinetics | 1 | 2015 | 225 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 127 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 132 | 0.030 |
Why?
|
| Smoking | 1 | 2015 | 194 | 0.030 |
Why?
|
| Mutation | 1 | 2015 | 383 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2013 | 53 | 0.030 |
Why?
|
| Obesity | 1 | 2015 | 291 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2015 | 428 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2013 | 323 | 0.030 |
Why?
|
| Sucrose | 1 | 2011 | 17 | 0.030 |
Why?
|
| Tyrosine | 1 | 2011 | 23 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 40 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 2011 | 27 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2011 | 59 | 0.030 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2011 | 15 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2011 | 495 | 0.020 |
Why?
|
| Aging | 1 | 2015 | 1593 | 0.020 |
Why?
|